Filing Details
- Accession Number:
- 0001238403-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-02 18:15:32
- Reporting Period:
- 2023-06-01
- Accepted Time:
- 2023-06-02 18:15:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238403 | K Daniel Spiegelman | 320 Wakara Way Salt Lake City UT 84108 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-01 | 15,151 | $0.00 | 49,131 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-06-02 | 8,638 | $23.01 | 40,493 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
